Fluorescence in situ hybridization identifies high risk Barrett's patients likely to develop esophageal adenocarcinoma.
Brankley SM, Halling KC, Jenkins SM, Timmer MR, Iyer PG, Smyrk TC, Barr Fritcher EG, Voss JS, Kipp BR, Campion MB, Lutzke LS, Minot DM, Wang KK.
Brankley SM, et al. Among authors: minot dm.
Dis Esophagus. 2016 Aug;29(6):513-9. doi: 10.1111/dote.12372. Epub 2015 Jun 5.
Dis Esophagus. 2016.
PMID: 26043762
Free PMC article.